MedTrace Logo

Analgesic Additives to Epidural Bupivacaine in Normal Labor

NCT05746351 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2023-02-27

No results posted yet for this study

Summary

The aim of the study will be to compare the role of Dexmedetomidine, Nalbuphine and fentanyl as additives to epidural bupivacaine in painless vaginal delivery as regard of effectiveness analgesia and maternal safety.

Conditions

  • Labor Pain

Interventions

DRUG

Dexmedetomidine

a group will receive epidural Bupivacaine with Dexmedetomidine in normal labor

DRUG

fentanyl

a group will receive epidural Bupivacaine with fentanyl in normal labor

DRUG

Nalbuphine

a group will receive epidural Bupivacaine with Nalbuphine in normal labor

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Zein EA Zareh Hassan, professor · Assiut University

  • Elwani Eldramy Elsenosi, professor · Assiut University

  • Khaled Tolba Younes, Lecturer · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-31
Primary Completion
2025-03-31
Completion
2025-07-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05746351 on ClinicalTrials.gov